MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles

Magnetic Resonance in Medicine

Volumn 49, Issue 3, 2003, Pages 403-408

  Artemov, Dmitri ^a   Mori, Noriko ^a   Okollie, Baasil ^a   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Avidin biotin system; Her 2 neu receptors; Iron oxide nanoparticles; MRI

Indexed keywords

AMINO ACIDS; CELL MEMBRANES; CYTOLOGY; DISEASES; MAGNETIC NANOPARTICLES; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS; METAL NANOPARTICLES; MOLECULAR IMAGING; MONOCLONAL ANTIBODIES;

AVIDIN BIOTIN SYSTEM; BIOMEDICAL APPLICATIONS; BREAST CANCER CELLS; EXPRESSION LEVELS; HER-2/NEU RECEPTORS; IRON OXIDE NANOPARTICLE; MR CONTRAST AGENTS; SUPERPARAMAGNETIC NANOPARTICLES;

IRON OXIDES;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MACS STREPTAVIDIN MICROBEADS; MONOCLONAL ANTIBODY; NANOPARTICLE; RECEPTOR; STREPTAVIDIN; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER STAGING; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION;

EID: 0037373410     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10406     Document Type: Article

References (28)

1. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-333.
2. van Roessel P, Brand AH. Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins. Nat Cell Biol 2002;4:E15-20.
3. Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L, Hasegawa S, Bouvet M, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR, Penman S, Hoffman RM. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci USA 2000;97:1206-1211.
4. Contag PR, Olomu IN, Stevenson DK, Contag CH. Bioluminescent indicators in living mammals. Nat Med 1998;4:245-247.
5. Bulte JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 1999;96:15256-15261.
6. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imag 1997;7:258-263.
7. Gohr-Rosenthal S, Schmitt-Willich H, Ebert W, Conrad J. The demonstration of human tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic resonance imaging. Invest Radiol 1993;28:789-795.
8. Kobayashi H, Sato N, Kawamoto S, Saga T, Hiraga A, Haque TL, Ishimori T, Konishi J, Togashi K, Brechbiel MW. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconjug Chem 2001;12:100-107.
9. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998;4:623-626.
10. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999;76:103-109.
11. Kang HW, Josephson L, Petrovsky A, Weissleder R, Bogdanov A Jr. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem 2002;13:122-127.
12. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 1992;25:148-157.
13. Go KG, Bulte JW, de Ley L, The TH, Kamman RL, Hulstaert CE, Blaauw EH, Ma LD. Our approach towards developing a specific tumour-targeted MRI contrast agent for the brain. Eur J Radiol 1993;16:171-175.
14. Clarke C, Titley J, Davies S, O'Hare MJ. An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. Epithel Cell Biol 1994;3:38-46.
15. Venter DJ, Tuzi NL, Kumar S, Gullick WJ. Overexpression of the cerbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 1987;2:69-72.
16. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-712.
17. DeGiovanna M. Clinical significance of HER-2/neu overexpression. Philadelphia: Lippincott Williams & Wilkins; 1999.
18. Wang SC, Zhang L, Hortobagyi GN, Hung MC. Targeting HER2: recent developments and future directions for breast cancer patients. Semin Oncol 2001;28:21-29.
19. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987;28:1294-1302.
20. Shapiro HM. Practical flow cytometry. New York: Alan R. Liss; 1988.
21. Gullick WJ, Berger MS, Bennett PL, Rothbard JB, Waterfield MD. Expression of the c-erbB-2 protein in normal and transformed cells. Int J Cancer 1987;40:246-254.
22. Cremonesi M, Ferrari M, Chinol M, Stabin MG, Grana C, Prisco G, Robertson C, Tosi G, Paganelli G. Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients. Eur J Nucl Med 1999;26:110-120.
23. Koenig SH, Gillis P. Transverse relaxation (1/T2) of solvent protons induced by magnetized spheres and its relevance to contrast enhancement in MRI. Invest Radiol 1988;23 Suppl 1:S224-228.
24. Gillis P, Roch A, Brooks RA. Corrected equations for susceptibility-induced T2-shortening. J Magn Reson 1999;137:402-407.
25. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J Magn Reson Imag 2001;14:72-77.
26. Bremer C, Weissleder R. In vivo imaging of gene expression. Acad Radiol 2001;8:15-23.
27. Bryant LH Jr, Brechbiel MW, Wu C, Bulte JW, Herynek V, Frank JA. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imag 1999;9:348-352.
28. Sato N, Kobayashi H, Hiraga A, Saga T, Togashi K, Konishi J, Brechbiel MW. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn Reson Med 2001;46:1169-1173.